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Abstract 
Background: Acquired radioresistance during radiotherapy is considered as the most important reason for local 
tumor recurrence or treatment failure. Circular RNAs (circRNAs) have recently been identified as microRNA sponges 
and involve in various biological processes. The purpose of this study is to investigate the role of circRNAs in the radi-
oresistance of esophageal cancer.
Methods: Total RNA was isolated from human parental cell line KYSE-150 and self-established radioresistant esopha-
geal cancer cell line KYSE-150R, and hybridized to Arraystar Human circRNA Array. Quantitative real-time PCR was 
used to confirm the circRNA expression profiles obtained from the microarray data. Bioinformatic tools including gene 
ontology (GO) analysis, KEGG pathway analysis and network analysis were done for further assessment.
Results: Among the detected candidate 3752 circRNA genes, significant upregulation of 57 circRNAs and down-
regulation of 17 circRNAs in human radioresistant esophageal cancer cell line KYSE-150R were observed compared 
with the parental cell line KYSE-150 (fold change ≥2.0 and P < 0.05). There were 9 out of these candidate circRNAs 
were validated by real-time PCR. GO analysis revealed that numerous target genes, including most microRNAs were 
involved in the biological processes. There were more than 400 target genes enrichment on Wnt signaling pathway. 
CircRNA_001059 and circRNA_000167 were the two largest nodes in circRNA/microRNA co-expression network.
Conclusions: Our study revealed a comprehensive expression and functional profile of differentially expressed circR-
NAs in radioresistant esophageal cancer cells, indicating possible involvement of these dysregulated circRNAs in the 
development of radiation resistance.
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Background
Esophageal cancer is the eighth most frequently diag-
nosed and the sixth highest mortality rate cancer in the 
world [1]. The 5-year survival rate of esophageal can-
cer patients with localized disease is less than 20  % [2]. 
Radiation therapy (RT) plays a crucial role in the treat-
ment of esophageal cancer [3]. Although complex 
multidisciplinary methods incorporating surgery, chem-
otherapy, and radiotherapy had been applied in the treat-
ment of esophageal cancer, the rate of local recurrence 
and distant metastasis remains high [4, 5]. Radiotherapy 
resistance has been considered as one of the most impor-
tant reasons for local tumor recurrence or treatment fail-
ure [6].
Circular RNAs (circRNAs), unlike the well known lin-
ear RNA, forms a covalently closed continuous loop 
[7, 8]. CircRNAs are integral, conserved, and demon-
strated to be resistant to RNase R treatment [9–11]. 
With the advent of novel biochemical and computa-
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a research hotspot in the RNA field [12]. Accumulating 
evidence demonstrated that circRNAs involve in the 
development of several types of diseases, such as Alzhei-
mer’s disease [13], atherosclerotic vascular disease [14] 
and cancer [15, 16]. Recent studies found that circRNAs 
can function as microRNAs (miRNAs) sponges [17, 18], 
RNA-binding protein sequestering agents, and nuclear 
transcriptional regulators. The recently identified cir-
cRNA, ciRS-7, which acts as a designated miR-7 sponge, 
involves in competing in endogenous RNA networks 
[19].
We previously developed a radioresistant esophageal 
squamous cancer cell line (KYSE-150R) by irradiating 
esophageal cancer cells KYSE-150 with gradient dose 
[20–22]. To explore the underlying molecular regulation 
mechansim of circRNAs in the radioresistance, circu-
lar RNA microarray was used to detect the differential 
expressed circRNAs between radioresistant esophageal 
cell line KYSE-150R and the parental cell line KYSE-150. 
Our results suggested that the aberrant expression of 
circRNAs may play a role in transformation of radiation 
resistance of esophageal cancer cells.
Methods
Cell culture and reagents
Human esophageal squamous cancer cell lines KYSE-150 
were purchased from the American Type Culture Collec-
tion (Manassas, VA, USA). Radioresistant cell line KYSE-
150R has been previously established in our department 
by gradient dose irradiation treatment. Both KYSE-150 
and KYSE-150R were cultured in RPMI-1640 (Gibco, 
Life Technologies Inc., Grand Island, NY, USA) with 
100 unit/ml of penicillin, 100 mg/ml of streptomycin, and 
10 % fetal bovine serum at 37 °C in a humidified incuba-
tor containing 5 % CO2. The cell lines were sub-cultured 
every 2–3 days following digestion at room temperature 
with 0.5  ml trypsin/EDTA per well (Sigma-Aldrich Ltd, 
UK).The viability was reported as the percentage of the 
viable cells number to the total cells number. There was 
an average viability over 95  %, determined by Trypan 
Blue staining.
RNA isolation, purification and hybridization
Three samples were collected from each of the two cell 
cultural groups and used for the following RNA extrac-
tion. Total RNA from each sample was treated with 
Rnase R (Epicentre, Inc.) to remove linear RNAs and 
to enrich circRNAs. Then, the enriched circRNAs were 
amplified and transcribed into fluorescent cRNA utiliz-
ing a random priming method (Arraystar Super RNA 
Labeling Kit; Arraystar). The labeled cRNAs were puri-
fied by RNeasy Mini Kit (Qiagen). The concentration 
and specific activity of the labeled cRNAs (pmol Cy3/
μg cRNA) were measured by NanoDrop ND-1000. One 
μL of each labeled cRNA was fragmented by adding 
5μL 10×  Blocking Agent and 1 μL of 25× Fragmenta-
tion Buffer, and then the mixture was heated at 60 °C for 
30 min. Finally 25 μL 2× Hybridization buffer was added 
to dilute the labeled cRNA. Hybridization solution of 
50 μL was dispensed into the gasket slide and assembled 
to the circRNA expression microarray slide. The slides 
were incubated for 17 h at 65 °C in an Agilent Hybridiza-
tion Oven. The hybridized arrays were washed, fixed and 
scanned using the Agilent Scanner G2505C.
Microarray data analysis
Scanned images were imported into Agilent Feature 
Extraction software (version 11.0.1.1) for raw data extrac-
tion. Quantile normalization of raw data and subsequent 
data processing were performed using the R software 
package. After quantile normalization of the raw data, 
low intensity filtering was performed. The circRNAs 
with at least 3 out of 6 samples flagged in “P” or “M” (“all 
targets value”) were retained for further analysis. When 
comparing the profile differences between two groups 
(such as disease versus control), the “fold change” (i.e. the 
ratio of the group averages) between the groups for each 
circRNA was computed. The statistical significance of the 
difference may be conveniently estimated by t test. Cir-
cRNAs having fold changes ≥2 and P values <0.05 were 
selected as of significantly differential expression.
Real‑time PCR validation
Quantitative Real-time PCR was used to confirm the 
circRNA expression profiles obtained from the micro-
array data. Total RNA was extracted from cells using 
Trizol Reagent (Invitrogen) and reversely transcribed 
into cDNA using Super Script TM III Reverse Tran-
scriptase (Invitrogen) according to a standard proto-
col. The relative gene expression was determined using 
ViiA 7 Real-time PCR System (Applied Biosystems). All 
samples were normalized to the signal generated from 
GAPDH (Sangon Biotech, Shanghai, China). Data was 
shown as fold change (2−ΔΔCt) and analyzed initially 
using Opticon Monitor Analysis Software V2.02 (MJ 
Research, Waltham, MA, USA). Triplicates were per-
formed for each sample in three independent experi-
ments. Primer sequences were presented in Additional 
file 1: Table S1.
MicroRNA prediction
The circRNA/microRNA interaction was predicted 
with Arraystar’s home-made miRNA target prediction 
software (Rockville, USA), whose principles are based 
on the TargetScan and miRanda prediction algorithm. 
The differentially expressed circRNAs within all the 
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comparisons were annotated in detail with the circRNA/
miRNA interaction information.
MicroRNA target genes prediction and GO analysis
To further investigate the functional roles of microRNA, 
putative targets of miRNAs were predicted by TargetS-
can software. GO analysis was performed to explore 
the functional roles of target genes in terms of biologi-
cal processes, cellular components and molecular func-
tions. Biological pathways defined by Kyoto Encyclopedia 
of Genes and Genomes (KEGG), Biocarta and Reactome 
(http://www.genome.jp/kegg/) were identified by Data-
base for Annotation, Visualization and Integrated Dis-
covery (DAVID; http://www.david.abcc.ncifcrf.gov/).
CircRNA‑microRNA co‑expression network
To further elucidate correlations between circRNAs and 
microRNA, potential microRNA-circRNA-mRNA inter-
action analysis was conducted by Cytoscape. The size of 
each node represents the number of putative microRNA 
functionally connected to each circRNA.
Statistical analysis
The results were reported as mean  ±  SD for tripli-
cate measurements. Statistically significant differences 
between groups were estimated by the Student’s t test 




The expression of 3752 human circRNAs was quanti-
tated for esophageal cancer KYSE-150R and KYSE-150 
cell samples using microarray platform (Additional file 2: 
Table S2). Hierarchical clustering and scatter plot visuali-
zation showed that the circRNAs expression levels were 
distinguishable and variations (Fig.  1). The expression 
profiles of 74 circRNAs were differentially expressed (fold 
change ≥2.0 and P < 0.05) between the KYSE-150R and 
KYSE-150 cells, in which 57 circRNAs were found to be 
upregulated and 17 circRNAs were downregulated more 
than two-fold in KYSE-150R cells (Tables  1, 2). Among 
these, The expression levels of circRNA_100385, cir-
cRNA_104983 and circRNA_001059 were upregulated in 
KYSE-150R by 41.06, 11.68 and 6.16-folds, respectively. 
Meanwhile, circRNA_101877, circRNA_102913, and 
circRNA_000695 were downregulated by 3.53, 2.69 and 
2.51-folds, respectively.
Real‑time quantitative PCR validation
To validate the microarray profiling expression data, real-
time quantitative RT-PCR revealed 4 upregulated and 5 
downregulated expressed circRNAs as shown in Fig.  2. 
Expression levels detected by the two methods were con-
sistent with each other, demonstrating the high reliability 
of the microarray expression results.
MicroRNA prediction and bioinformatics analyses
MicroRNA prediction was done with Arraystar’s home-
made miRNA target prediction software based on 
miRanda (Table 3; Additional file 3: Table S3, Additional 
file 4: Table S4). There were 12 out of 17 downregulated 
circRNAs had target microRNAs. The results of Gene 
Ontology enrichment analysis on the up and down regu-
lated circRNAs with identified target genes were shown 
in Fig.  3 and Additional file  5: Table S5. Gene Ontol-
ogy analysis revealed that numerous target genes were 
involved in the biological processes, such as cellular pro-
cess, regulation of biological process, metabolic process, 
etc. These processes were associated with human tumo-
rigenesis and metastasis. KEGG analysis showed that 
there were 10 pathways related to upregulated circRNAs, 
including Olfactory transduction, Spliceosome, Gluta-
matergic synapse, and Phosphatidylinositol signaling 
system, and 17 pathways related to downregulated cir-
cRNAs, including Neurotrophin signaling pathway, Wnt 
signaling pathway, Microbial metabolism in diverse envi-
ronments and Insulin signaling pathway (Fig.  4; Addi-
tional file 6: Table S6). Especially, there were more than 
400 target genes enrichment in Wnt signaling pathway.
CircRNA‑microRNA co‑expression network
Potential connections between circRNA and microRNA 
were explored by using Cytoscape. As shown in Fig.  5, 
CircRNA_001059 and circRNA_000167 were the two 
largest nodes in the network.
Discussion
Acquired radioresistance has been considered as one of 
the most important reasons causing treatment failure for 
esophageal cancer patients. In this study, we explored the 
expression patterns of circRNAs between radioresistant 
esophageal cancer cell line KYSE-150R and its parental 
cell line KYSE-150 with Arraystar Circular RNA Micro-
array to investigate the mechanisms of acquired radiore-
sistance of esophageal cancer. Differentially expressed 
profiles of circRNAs in radioresistant esophageal can-
cer cells were observed and validated compared with 
the parental esophageal cancer cells, indicating possible 
involvement of these dysregulated circRNAs in the devel-
opment of radiation resistance of esophageal cancer cells.
CircRNAs are discovered as new special kind of ubiq-
uitous endogenous noncoding RNAs [23]. Recent evi-
dences revealed that circRNAs can function as miRNA 
sponges and regulate parent gene expression to affect 
disease. Despite the potential importance of circRNAs 
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reported in several types of cancer [24, 25], there is 
no reported studies on the functional roles of circR-
NAs in the radiation resistance of cancer. In this study, 
there were 57 circRNAs significantly upregulated and 
17 circRNAs significantly downregulated in the KYSE-
150R cell lines compared with KYSE-150, respectively. 
In which, circRNA_100385, circRNA_104983 and 
circRNA_001059 were upregulated with top magni-
tudes. CircRNA_101877, circRNA_102913, and cir-
cRNA_000695 were downregulated with top magnitudes. 
The expression pattern of these circRNAs were validated 
by qRT-PCR, and consistent results were observed. Our 
results indicated that the altered expression levels of cir-
cRNAs may be related to their involvement in the tran-
scription level regulation on the radiation resistance of 
esophageal cancer cells. Aberrant expression of circR-
NAs has been linked to carcinogenesis and the malignant 
behavior of many different cancer. The abundance of a 
circRNA called hsa_circ_002059 has been reported to be 
significantly downregulated and suggested as a potential 
diagnostic marker for gastric cancer [26]. Qin M et  al. 
[27] found that hsa_circ_0001649 may play a role in tum-
origenesis and metastasis of hepatocellular carcinoma. 
Li et al. [28] reported that cir-ITCH might influence the 
expression level of ITCH and may be involved in the 
development of esophageal squamous cell carcinoma. 
However, no obvious changes of cir-ITCH was observed 
in this study, suggesting it may have no contribution to 
the radioresistance of esophageal cancer cells.
Despite the lack of knowledge of the exact functions of 
most circRNAs, we investigated the potential targets of 
these altered miRNAs. In a total, 57 upregulated circR-
NAs were identified to regulate the expression level of 120 
microRNAs using the miRanda software, and 12 down-
regulated circRNAs were identified to regulate 36 micro-
RNAs. According to the findings of Denzler et  al. [29] 
low levels of circRNAs may not be sufficient to affect the 
target miRNAs. The circRNA-microRNA co-expression 
network analysis were conducted for our Top-5 circR-
NAs in this study. Two potential crucial circRNAs, cir-
cRNA_001059 and circRNA_000167 were identified to be 
influential on target miRNAs. CircRNAs were believed to 
negatively regulate miRNAs, and contribute substantially 
to the competing endogenous RNA (ceRNA) network. It 
has been reported that ciRS-7, as a circular miR-7 inhibi-
tor, harbors more than 60 conventional miR-7 binding 
Fig. 1 CircRNA microarray expression data between the KYSE-150 and KYSE-150R cells. a Hierarchical clustering shows a distinguishable circRNA 
expression profiling among KYSE-150 and KYSE-150R cell. b Box plots show the distribution of circRNAs for the two compared samples. The distribu-
tions were nearly the same after normalization. c Scatter plots assess the circRNA expression variation between the two compared groups. The 
circRNAs above the top green line and below the bottom green line indicated more than twofold changes of circRNAs between the two compared 
samples
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Table 1 Upregulated circRNAs in the KYSE-150R compared with KYSE-150
ProbeID CircRNA Genesymbol Chrom FC (abs)
ASCRP000770 hsa_circRNA_100385 PRRX1 chr1(+):170688866170695542 41.06
ASCRP005230 hsa_circRNA_104983 NHS chrX(+):1770586117710588 11.69
ASCRP000189 hsa_circRNA_001059 LIN52 chr14(+):7455167774551959 6.16
ASCRP001355 hsa_circRNA_100984 FOXRED1 chr11(+):126142863126143349 5.96
ASCRP000752 hsa_circRNA_100367 DCAF8 chr1(−):160206924160231148 5.62
ASCRP004073 hsa_circRNA_103783 NSUN2 chr5(−):66233266625782 5.19
ASCRP000699 hsa_circRNA_100312 MAN1A2 chr1(+):117944807117984947 5.04
ASCRP005194 hsa_circRNA_104947 PRRC2B chr9(+):134330462134334743 3.67
ASCRP000700 hsa_circRNA_100313 MAN1A2 chr1(+):117957334117963271 3.46
ASCRP003691 hsa_circRNA_103393 CCDC66 chr3(+):5662699756628056 3.40
ASCRP002905 hsa_circRNA_102592 MYH14 chr19(+):5072087150721028 3.34
ASCRP004116 hsa_circRNA_103826 ZNF131 chr5(+):4316135043162033 3.18
ASCRP004597 hsa_circRNA_104334 MPP6 chr7(+):2466328424708279 3.10
ASCRP004358 hsa_circRNA_104084 LINC00340 chr6(+):2202056722056919 2.96
ASCRP003426 hsa_circRNA_103122 DONSON chr21(−):3495360734958487 2.91
ASCRP000085 hsa_circRNA_000629 KIF18B chr17(−):4301230343012398 2.88
ASCRP000698 hsa_circRNA_100311 MAN1A2 chr1(+):117944807117948267 2.88
ASCRP003235 hsa_circRNA_102928 RHBDD1 chr2(+):227729319227779067 2.86
ASCRP001219 hsa_circRNA_100845 MARK2 chr11(+):6366263063663105 2.83
ASCRP002541 hsa_circRNA_102213 USP36 chr17(−):7682332676825089 2.69
ASCRP002519 hsa_circRNA_102191 HN1 chr17(−):7314276073144766 2.67
ASCRP000062 hsa_circRNA_000543 MALAT1 chr11(+):6527249065272586 2.59
ASCRP000292 hsa_circRNA_001543 RSBN1L chr7(+):7737874077387395 2.58
ASCRP004442 hsa_circRNA_104169 SOBP chr6(+):107824860107827631 2.56
ASCRP003692 hsa_circRNA_103394 APPL1 chr3(+):5727688357301820 2.54
ASCRP004877 hsa_circRNA_104624 PCMTD1 chr8(−):5277340452773806 2.51
ASCRP000286 hsa_circRNA_001506 LAPTM4A chr2(−):2024080920240905 2.49
ASCRP001133 hsa_circRNA_100759 DENND5A chr11(−):92252069229179 2.38
ASCRP001576 hsa_circRNA_101213 RAN chr12(+):131357380131357465 2.35
ASCRP001668 hsa_circRNA_101309 TMCO3 chr13(+):114188359114193822 2.35
ASCRP003134 hsa_circRNA_102825 RAB3GAP1 chr2(+):135883750135884226 2.33
ASCRP002340 hsa_circRNA_102003 USP22 chr17(−):2091020820914622 2.30
ASCRP004596 hsa_circRNA_104333 MPP6 chr7(+):2466328424690331 2.30
ASCRP000391 hsa_circRNA_100001 SAMD11 chr1(+):871151874792 2.28
ASCRP002927 hsa_circRNA_102614 ASAP2 chr2(+):94909369499018 2.26
ASCRP001679 hsa_circRNA_101320 PRMT5 chr14(−):2339534123396023 2.26
ASCRP002384 hsa_circRNA_102049 TADA2A chr17(+):3579783835800763 2.25
ASCRP005237 hsa_circRNA_104990 POLA1 chrX(+):2482801424844718 2.25
ASCRP005013 hsa_circRNA_104763 UBAP2 chr9(−):3395328233996331 2.23
ASCRP002333 hsa_circRNA_101996 SPECC1 chr17(+):2010764520109225 2.23
ASCRP003820 hsa_circRNA_103522 FXR1 chr3(+):180685838180688146 2.21
ASCRP001777 hsa_circRNA_101418 CEP128 chr14(−):8129748681307112 2.18
ASCRP002683 hsa_circRNA_102364 DYM chr18(−):4678337946808545 2.18
ASCRP003659 hsa_circRNA_103361 SMARCC1 chr3(−):4771968747727660 2.18
ASCRP000064 hsa_circRNA_000554 PRB4 chr12(−):1119961811248400 2.17
ASCRP001819 hsa_circRNA_101468 TJP1 chr15(−):3005334130092905 2.16
ASCRP005238 hsa_circRNA_104991 POLA1 chrX(+):2482801424861794 2.15
ASCRP001818 hsa_circRNA_101467 TJP1 chr15(−):3005334130065560 2.13
ASCRP003032 hsa_circRNA_102720 RTN4 chr2(−):5521462655214834 2.12
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sites, which is far more than any known linear sponges 
[30]. Sex-determining region Y (SRY) was another identi-
fied miRNA sponge and functioned as a miR-138 sponge 
[31]. According to our results, we hypothesized that cir-
cRNA_001059 may act as an inhibitor of miRNA by 
binding several specific miRNAs, including miR-30c-1*, 
miR-30c-2*, miR-122*, miR-139-3p, miR-339-5p and miR-
1912. Our results implied that it is worthwhile to further 
investigate these novel dysregulated circRNAs as micro-
RNA sponges and their potential biological functions in 
the development of radiation resistance.
In this study, GO analysis and KEGG pathway annota-
tion were conducted to investigate the functions of related 
microRNAs [32]. GO enrichment analysis revealed that 
target genes were involved in the regulation of crucial 
Table 1 continued
ProbeID CircRNA Genesymbol Chrom FC (abs)
ASCRP000314 hsa_circRNA_001676 PPP1R12A chr12(−):8018015380183460 2.11
ASCRP003844 hsa_circRNA_103546 LPP chr3(+):188202379188242575 2.09
ASCRP001842 hsa_circRNA_101491 MAPKBP1 chr15(+):4210308042105299 2.09
ASCRP002653 hsa_circRNA_102334 SS18 chr18(−):2361236223637706 2.07
ASCRP003119 hsa_circRNA_102810 RALB chr2(+):121036193121047333 2.06
ASCRP002883 hsa_circRNA_102570 ERCC2 chr19(−):4586052745860957 2.05
ASCRP004893 hsa_circRNA_104640 CSPP1 chr8(+):6801813968028357 2.04
ASCRP003216 hsa_circRNA_102908 BARD1 chr2(−):215632205215646233 2.01
Table 2 Downregulated circRNAs in the KYSE-150R compared with KYSE-150
probeID circRNA Genesymbol Chrom FC (abs)
ASCRP002219 hsa_circRNA_101877 RFWD3 chr16(−):74670243 74671868 3.53
ASCRP003221 hsa_circRNA_102913 ATIC chr2(+):216177220 216190861 2.69
ASCRP000100 hsa_circRNA_000695 EEFSEC chr3(+):128102470 128102926 2.51
ASCRP000018 hsa_circRNA_000167 RPPH1 chr14(−):20811404 20811554 2.47
ASCRP001778 hsa_circRNA_101419 STON2 chr14(−):81837331 81837529 2.42
ASCRP001605 hsa_circRNA_101242 PAN3 chr13(+):28830428 28855516 2.39
ASCRP001111 hsa_circRNA_100737 TOLLIP chr11(−):1307231 1317024 2.3
ASCRP003406 hsa_circRNA_103102 DIDO1 chr20(−):61537238 61545758 2.3
ASCRP001876 hsa_circRNA_101525 PIGB chr15(+):55621921 55634000 2.25
ASCRP004888 hsa_circRNA_104635 MTFR1 chr8(+):66582107 66582253 2.21
ASCRP003466 hsa_circRNA_103165 PI4KA chr22(−):21161649 21167794 2.2
ASCRP000390 hsa_circRNA_002178 RPPH1 chr14(−):20811436 20811534 2.16
ASCRP000535 hsa_circRNA_100146 EIF3I chr1(+):32691771 32692131 2.11
ASCRP000950 hsa_circRNA_100571 PDSS1 chr10(+):27024168 27024508 2.09
ASCRP003989 hsa_circRNA_103695 KLHL8 chr4(−):88116475 88116842 2.07
ASCRP004979 hsa_circRNA_104729 GLIS3 chr9(−):4117767 4118881 2.07
ASCRP001678 hsa_circRNA_101319 RBM23 chr14(−):23378691 23380612 2.01
Fig. 2 CircRNA expression changes validated by qRT-PCR. Valida-
tion of microarray analysis data by qRT-PCR. The expression levels of 
9 circRNAs were determined by qRT-PCR. Each qRT-PCR assay was 
performed at least three times. *P < 0.05
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biological processes, indicating that regulating these genes 
in the cellular response is of great importance during the 
development of radioresistance. Among the upregulated 
pathways found in this study, phosphatidylinositol sign-
aling pathway had been reported to be a key mediator of 
tumor cell responsiveness to radiation [33]. Phosphati-
dylinositol 3-kinase (PI3K)/Akt pathway accelerates the 
repair of DNA-DSB (DNA double-strand breaks), and 
consequently, its activation leads to therapy resistance 
[33]. Wnt signaling pathway which corresponds to down-
regulated circRNAs had also been reported to play pre-
dominant roles in radioresistance in Glioblastoma [34] and 
prostate cancer [35]. These results were also in line with 
the observations reported in our previous study [21].
Conclusions
In a conclusion, a unique set of circRNAs and their 
expression profiles were found in radioresistant esopha-
geal cancer cells. Furthermore, their potential roles were 
investigated by bioinformatics analysis. Pathway analysis 
suggested that Wnt signaling pathway may be involved 
in the radioresistance. Network analysis uncovered two 
potential key circRNAs, i.e. circRNA_001059 and cir-
cRNA_000167. Our results would be helpful for future 
Table 3 Target gene numbers of circRNA-miRNA
CircRNA MiRNA MiRNA::circRNA MiRNA::circRNA target_loca‑
tion
MiRNA::target
Up 57 120 120::53 120::149 120::40335
Down 12 36 36::12 36::12 36::38979
Fig. 3 Gene ontology enrichment analysis. a Gene ontology enrichment corresponds to the upregulated circRNAs. b Gene ontology enrichment 
corresponds to the downregulated circRNAs
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Fig. 5 CircRNA-microRNA co-expression network. The circRNA-microRNA co-expression network as drawn with the cytoscape software. The size of 
each node represent functional connectivity of each circRNA. CircRNA_001059 and circRNA_000167 were the two largest nodes in the network
Fig. 4 KEGG pathway analysis. a Pathways correspond to the upregulated circRNAs. b Pathways correspond to the downregulated circRNAs. c Wnt 
signaling pathway. Red marked nodes are associated with target genes enrichment on Wnt signaling pathway
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studies on investigating the molecular functions of circR-
NAs in radiotherapy resistance.
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